News

Applied Clinical Trials Online11h

Phase III VAYHIT2 Trial Demonstrates Ianalumab Plus Eltrombopag Extends Disease Control in Primary Immune Thrombocytopenia

In the Phase III VAYHIT2 trial, ianalumab combined with eltrombopag significantly prolonged time to treatment failure and ...
Applied Clinical Trials Online13h

Phase III EV-303/KEYNOTE-905 Shows Padcev Plus Keytruda Improves Event-Free and Overall Survival in Muscle-Invasive Bladder Cancer

In this Phase III trial, the Padcev-Keytruda combination used as both neoadjuvant and adjuvant therapy significantly improved event-free and overall survival, as well as pathologic complete response, ...
Applied Clinical Trials Online21h

FDA Review Changes and the Impact on Trial Design

In this video interview, Meri Beckwith, Co-CEO of Lindus Health, discusses recent Complete Response Letters issued to Replimune and Capricor, explaining how shifts in FDA reviewers can affect ...